Rollins Q2 Miss Seen as Seasonal, H2 Recovery Expected, Morgan Stanley Says

MT Newswires Live
07/24

Rollins' (ROL) Q2 results fell short of expectations as a slower-than-usual start to the peak summer pest season weighed on organic revenue growth, though Morgan Stanley expects performance to improve in the second half of the year.

The brokerage said in a Thursday note that weaker-than-expected organic revenue growth reflected softer residential digital lead volumes, particularly at Orkin. However, lead volumes recovered in late June and remained strong through July, while healthy customer retention, pricing and underlying consumer demand point to a stronger third quarter.

Morgan Stanley expects easier year-over-year comparisons and favorable El Nino-driven weather to support H2 growth but lowered its 2026 adjusted EBITDA estimate by 4% following the Q2 miss and lower expected Q3 incremental margins.

Management said business trends strengthened toward the end of June and into July, according to the report.

Morgan Stanley maintained its overweight rating on the stock and cut its price target to $60 from $65.

Rollins shares were down 2.1% in Friday trading.

Price: 38.61, Change: -0.83, Percent Change: -2.10

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10